» Authors » B Gicquel

B Gicquel

Explore the profile of B Gicquel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 106
Citations 4662
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pierre-Audigier C, Talla C, Alame-Emane A, Audigier B, Grall N, Ruimy R, et al.
Int J Tuberc Lung Dis . 2020 Apr; 24(4):428-435. PMID: 32317068
Tuberculosis (TB) incidence is declining overall in France, but not in Paris where some areas remain relative hot spots for TB. To obtain a better knowledge of local TB epidemiology...
2.
Alame-Emane A, Xu P, Pierre-Audigier C, Cadet-Daniel V, Shen X, Sraouia M, et al.
Int J Tuberc Lung Dis . 2015 May; 19(6):679-84. PMID: 25946359
Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) constitute a major public health concern. Objective: To determine the timing of pncA mutations that confer pyrazinamide (PZA)...
3.
Pierre-Audigier C, Surcouf C, Cadet-Daniel V, Namouchi A, Heng S, Murray A, et al.
Int J Tuberc Lung Dis . 2012 Jan; 16(2):221-3, i-ii. PMID: 22236923
In a study performed in Cambodia, a higher number of tuberculosis (TB) strains with mutations in the pncA gene associated with pyrazinamide resistance (PZA-R) was found in fluoroquinolone-resistant (FQ-R) multidrug-resistant...
4.
Jackson M, Reinaldo Camacho L, Gicquel B, Guilhot C
Methods Mol Med . 2011 Feb; 54:59-75. PMID: 21341069
Gene replacement and transposon mutagenesis are two complementary tools that have been widely used to perform genetic studies in various living organisms. In mycobacteria, and especially in the Mycobacterium tuberculosis...
5.
Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kelembho E, Barilone N, Zandanga G, Rauzier J, et al.
Int J Tuberc Lung Dis . 2010 May; 14(6):782-5. PMID: 20487620
Multidrug-resistant (MDR) strains were identified in 40% of 54 strains from patients presenting with tuberculosis (TB) treatment failure or relapse in Bangui, Central African Republic. Results obtained with the MTBDRplus...
6.
Quintero-Macias L, Santos-Mendoza T, Donis-Maturano L, Silva-Sanchez A, Aguilar D, Orozco H, et al.
Scand J Immunol . 2009 Dec; 71(1):20-8. PMID: 20017806
To ascertain the in vivo role of mycobacterial lipids phthiocerol dimycocerosates (PDIM) in experimental murine tuberculosis (Tb), airways infection was used to compare the parental virulent clinical isolate MT103 with...
7.
Cardona P, Asensio J, Arbues A, Otal I, Lafoz C, Gil O, et al.
Vaccine . 2009 Apr; 27(18):2499-505. PMID: 19368792
Safety is one of the main concerns for attenuated live vaccine candidates. Here we extend the stability and attenuation studies of the promising tuberculosis vaccine candidate based on Mycobacterium tuberculosis...
8.
Aguilar D, Infante E, Martin C, Gormley E, Gicquel B, Hernandez Pando R
Clin Exp Immunol . 2007 Jan; 147(2):330-8. PMID: 17223975
The Mycobacterium tuberculosis phoP mutant strain SO2 has been shown previously to be more attenuated than Mycobacterium bovis bacillus Calmette-Guérin (BCG) and confers protective immunity against tuberculosis in mice and...
9.
Scandurra G, Williams R, Triccas J, Pinto R, Gicquel B, Slobedman B, et al.
Microbes Infect . 2006 Dec; 9(1):87-95. PMID: 17194612
The control of mycobacterial infections is dependent on the finely tuned synergism between the innate and adaptive immune responses. The macrophage is the major host cell for Mycobacterium tuberculosis and...
10.
Santangelo M, McIntosh D, Bigi F, Armoa G, Campos A, Ruybal P, et al.
Vaccine . 2006 Oct; 25(6):1104-13. PMID: 17049681
Babesia bovis is the causative agent of babesiosis, a tick-borne disease that is a major cause of loss to livestock production in Latin America. Vaccination against Babesia species represents a...